全球醫療事務外包市場 - 市場規模、佔有率、成長分析：按服務（醫療監測、醫學寫作和出版）、按行業（醫療設備、製藥和生物製藥） - 行業預測（2023-2030）

2021年全球醫療事務外包市場規模為14.9億美元，預測在預測期內（2023-2030年）年複合成長率為13.6%，從2022年的17億美元成長到2030年。2019年增至47.1億美元。

由於感染疾病和非感染疾病的流行導致臨床試驗大幅增加，全球醫療事務外包市場正在顯著擴大。臨床活動的激增急劇增加了對醫療設備和創新藥物的需求，從而增加了對醫療外包解決方案的需求。

此外，委外研發機構提供的極具吸引力的成本效益和一流服務的結合推動了這個市場的成長。嚴格法規的存在也強調了對專業能力的需求，進一步鞏固了市場預測。

這些要素共同創造了有利於醫事外包領域發展的環境。全球疫情大流行的影響波及各行業，包括醫療事務外包。

儘管法規和外包部門面臨障礙，但 COVID-19 的爆發要求製藥業專業人員改變醫療事務的慣例。這種調整導致了虛擬科學參與的激增和對科學交流的重視。從長遠來看，這些變化預計將再形成醫療事務團隊的結構和職能。

預計新領域將成為醫療事務領域不可或缺的一部分，例如透過特定醫療管道促進先進治療的獲得、與病患小組在專科護理中發揮關鍵作用。

醫藥和醫療設備領域面臨價格限制、嚴格法規、專利到期挑戰，導致報酬率下降。醫療事務業務正在成為生物製藥和製藥公司的策略和競爭工具，這主要是由於其節省成本的效果。

製藥和醫療設備企業透過將醫療事務業務委託給委外研發機構（CRO），可以減少業務費用、減少法律責任、加強法規合規性、避免程序瓶頸，可以透過與優秀外包合作夥伴的合作來實現。隨著公司努力最佳化其能力並應對充滿挑戰的企業環境，這種趨勢預計將持續下去。

在醫療保健領域，越來越需要具體證據來證明產品的有效性和安全性。醫療事務外包提供者在創建、評估和分發真實資料方面發揮著至關重要的作用。這些資料對於提高藥品和醫療設備的可靠性發揮作用。

該報告研究了全球醫療事務外包市場，並提供了市場概述、按服務、行業、地區分類的趨勢以及參與市場的公司概況。

目錄

執行摘要

母市場分析

市場規模

• 市場動態
• 促進因素
• 機會
• 抑制因素
• 任務

關鍵市場洞察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 智慧財產權分析
• 趨勢分析
• 啟動分析
• 原料分析
• 創新矩陣
• 研發線產品分析
• 總體經濟指標
• 頂級投資分析
• 關鍵成功要素
• 競爭程度

市場動態及預測

• 市場動態
• 促進因素
• 機會
• 抑制因素
• 任務
• 法規狀況
• 波特分析

全球醫療事務外包市場（按服務）

• 市場概況
• 醫療監測
• 醫學寫作/出版
• 醫療資訊
• 醫學科學聯絡員
• 其他

全球醫療事務外包市場（按行業）

• 市場概況
• 醫療設備、藥品和生物製藥

全球醫療事務外包市場（按地區）

• 市場概況
• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東/非洲

競爭形勢

• 主要企業簡介
  • IQVIA Inc.
  • Syneos Health Inc.
  • PAREXEL International Corporation
  • ICON plc
  • PPD公司
  • Pharmaceutical Product Development, LLC（PPD）
  • Covance Inc
  • PRA Health Sciences, Inc.
  • Medpace Holdings, Inc.
  • Charles River Laboratories International, Inc.
  • ProPharma Group
  • The Medical Affairs Company, LLC
  • Indegene, Inc
  • Ashfield Healthcare Communications Group
  • Accenture plc
  • MMS Holdings Inc.
  • Clinipace Worldwide
  • Max Neeman International
  • Freyr Solutions
  • Comprehend Systems, Inc.

Global Medical Affairs Outsourcing Market size was valued at USD 1.49 billion in 2021 and is poised to grow from USD 1.7 billion in 2022 to USD 4.71 billion by 2030, at a CAGR of 13.6% during the forecast period (2023-2030).

The global market for outsourcing medical affairs is undergoing significant expansion, driven by a notable increase in clinical trials due to the growing prevalence of communicable and non-communicable diseases. This surge in clinical activity has spiked demand for medical devices and innovative drugs, thereby intensifying the necessity for medical outsourcing solutions.

Furthermore, this market growth is propelled by the appealing amalgamation of cost-efficiency and top-notch services offered by contract research organizations. The presence of strict regulatory demands also underscores the requirement for specialized proficiency, further fortifying the market's prospects.

These factors collectively foster an environment conducive to the progression of the medical affairs outsourcing sector. The widespread effects of the global pandemic have reverberated across various industries, including medical affairs outsourcing.

Despite the hurdles confronted by regulatory and outsourcing units, the outbreak of COVID-19 has necessitated a shift in the routines of pharmaceutical industry professionals in medical affairs. This adjustment has given rise to a considerable surge in virtual scientific engagements and an elevated emphasis on scientific communication. In the long run, these transformations are predicted to reshape the configuration and duties of medical affairs teams.

Emergent domains, such as facilitating access to advanced treatments through specific healthcare channels, active engagement with patient groups, and pivotal roles in specialty care, are envisioned to become integral facets of the medical affairs realm.

Pharmaceutical and medical device sectors confront challenges like pricing constraints, rigorous regulations, and patent expirations, leading to narrowed profit margins. Contract medical affairs services are emerging as a strategic and competitive instrument among biopharmaceutical and pharmaceutical enterprises, primarily due to the cost-saving benefits they provide.

By delegating medical affairs services to contract research organizations (CROs), pharmaceutical and medical device companies can curtail operational expenses, mitigate liability exposure, enhance compliance with regulations, and avert procedural bottlenecks through partnerships with adept outsourcing collaborators. This inclination is likely to persist as businesses strive to optimize their functions and navigate the demanding corporate landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Affairs Outsourcing Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Driver

The healthcare sector's demand for tangible evidence to substantiate the effectiveness and safety of products is on the rise. In this context, providers of medical affairs outsourcing assume a pivotal role in producing, evaluating, and distributing real-world data. This data serves to bolster the credibility of pharmaceutical products and medical devices.

Restraint

Delegating medical affairs responsibilities externally can present obstacles in upholding uniform quality and ensuring alignment with internal benchmarks and regulatory mandates. To effectively address these challenges, organizations need to establish robust frameworks for oversight and evaluation.

Market Trends

The demand for real-world evidence is on a steady rise among pharmaceutical and medical device firms, as they seek to establish the effectiveness, safety, and value of their products. In this context, medical affairs outsourcing entities are assuming a pivotal role in the generation and analysis of real-world data. This support aids companies in making informed decisions grounded in evidence and facilitates the compilation of regulatory submissions.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune
• Research Methodology
• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition
• Market Dynamics & Outlook
• Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Medical Affairs Outsourcing Market by Services
• Market Overview
• Medical Monitoring
• Medical Writing & Publishing
• Medical Information
• Medical Science Liaisons
• Others
• Global Medical Affairs Outsourcing Market by Industry
• Market Overview
• Medical Devices and Pharma & biopharmaceuticals
• Global Medical Affairs Outsourcing Market Size by Region
• Market Overview
• North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
• IQVIA Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Syneos Health Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • PAREXEL International Corporation (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ICON plc (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • PPD, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Pharmaceutical Product Development, LLC (PPD) (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Covance Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • PRA Health Sciences, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Medpace Holdings, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Charles River Laboratories International, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • ProPharma Group (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • The Medical Affairs Company, LLC (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Indegene, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ashfield Healthcare Communications Group (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Accenture plc (Ireland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • MMS Holdings Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Clinipace Worldwide (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Max Neeman International (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Freyr Solutions (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Comprehend Systems, Inc. (USA)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments